Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FSV
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 4.10 1.84 1.77
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 41.34 16.82 11.90
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.47 23.39 22.83
Cash -11.07 4.10 4.61
Capex 7.55 -0.56 -0.60
Free Cash Flow -62.49 -0.75 2.00
Revenue 3.46 25.71 24.85
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.18 0.29 0.29
Operating Margin -42.74 0.03 0.06
ROA -0.18 < 0.005 < 0.005
ROE -2.15 < 0.005 < 0.005
ROIC -37.09 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FSV is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FSV is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FSV is permitted for members.